|
Index of reports
> Disability (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Kadian (Morphine) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Kadian side effects in 90 year old female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-08-09
Patient: 90 year old female
Reactions: Skin Exfoliation, Excoriation, Rash, Skin Reaction, Blister
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Clonazepam
Dosage: 125 ug;qd;po
Administration route: Oral
Indication: Analgesic Therapy
Start date: 2012-06-30
End date: 2012-07-09
Kadian
Dosage: 5 mg;q2h;po
Administration route: Oral
Indication: Analgesic Therapy
Metoclopramide Hydrochloride
Dosage: 10 mg;qd;po
Administration route: Oral
Indication: Nausea
Start date: 2012-06-19
End date: 2012-07-10
Ondansetron
Dosage: 4 po;bid;po
Administration route: Oral
Indication: Nausea
Start date: 2012-06-28
Oxycodone HCL
Dosage: 5 mg;prn;po
Administration route: Oral
Indication: Analgesic Therapy
Start date: 2012-06-28
End date: 2012-07-05
Possible Kadian side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-12
Patient: female, weighing 71.2 kg (156.7 pounds)
Reactions: Night Blindness, Vision Blurred, Dizziness, Visual Acuity Reduced
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Kadian
Indication: Pain
Levothyroxine Sodium
Indication: Thyroid Disorder
Lyrica
Lyrica
Lyrica
Indication: Fibromyalgia
Lyrica
Indication: Intervertebral Disc Degeneration
Other drugs received by patient: Vitamin B-12; Reclast; Calcium; Hydrochlorothiazide; Vitamin D; Vitamin E; Zoloft; Lipitor
|
